Perspectivas legales y sociales del uso de la telemedicina en el aborto farmacológico

Legal and social perspectives on the use of telemedicine in medical abortion

  • María Isabel Fernández Aranda Unidad de Ginecología y Obstetricia, Hospital Virgen del Rocío (Sevilla, España)
Palabras clave: Aborto inducido, Embarazo, Educación para la salud, Telemedicina
Key-words: Abortions induced, Pregnancy, Healthcare education, Telemedicine

Resumen

Abstract

Bibliografía

1. Grimes D, Benson J, Singh S, Romero M, Ganatra B, Okonofua FE, et al. Unsafe abortion: the preventable pandemic. Lancet. 2006;368: 1908–19.
2. Fiala C, Gemzell-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception. 2006;74:66–86.
3. World Health Organization. Aborto Seguro: Guía técnica y de políticas para sistemas de salud. Segunda edición 2012. [acceso 1 Abril 2018]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/77079/9789243548432_spa.pdf?sequence=1
4. Cleland K, Creinin MD, Nucatola D. Significant adverse events and outcomes after medical abortion. Obstet Gynecol. 2013;121:166-71.
5. Jiménez W, Acuña J. Avances en telesalud y telemedicina: estrategia para acercar los servicios de salud a los usuario.Acta Odontológica Colombiana, 2015.
6. Peetso T. Telemedicine: The Time to Hesitate is Over!», Eurohealth Incorporating Euro Observer. 2014; 20 (3):1.
7. Organización Mundial de la Salud, “Telemedicine Opportunities and developments in Members States. Report on the second global survey on eHealth. Global Observatory for eHealth series”, Organización Mundial de la Salud, vol. 2, 2010.
8. Saigí F, Torrent J, Jiménez A. Drivers of telemedicine use: comparative evidence from samples of Spanish, Colombian and Bolivian physicians. Implementation Science. 2014; 9:128.
9. Seguranyes G, Costa D, Fuentelsaz-Gallego C, Beneit JV, Carabantes D, Gómez-Moreno C, et al. Efficacy of a videoconfer-encing intervention compared with standard postnatal care at primary care health centres in Catalonia. Midwifery. 2014;30:764-771.
10. Fernández MI. Nuevas tecnologías en Atención Primaria como complemento en la asistencia gineco osbtétrica prestada por matronas. Opiniones, actitudes y uso de las TIC de usuarias del Área Sanitaria Norte de Córdoba. Matronas Hoy. 2014; 2(3):13-21.
11. Sethna C, Doull M. Spatial disparities and travel to freestanding abortion clinics in Canada. Women's Studies International Forum. 2013;38:52-62.
12. Norman W, Dickens B. Abortion by telemedicine: anequitable option for Irish women. BMJ. 2017;357:j2237.
13. Raymond E, Chong E, Hyland P. Increasing access to abortion with telemedicine. JAMA Intern Med. 2016;176:585-6.
14. Grossman D, Grindlay K, Buchacker T. Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet Gynecol. 2011;118:296-303.
15. Grossman D, Grindlay K. Safety of medical abortion provided through telemedicine compared with in person. Obstet Gyne-col. 2017;130:778-82.
16. Yang Y, Kozhimannil K. Medication abortion through telemedicine: implications of a ruling by the Iowa Supreme Court. Obstet Gynecol. 2016;127:313-6.
17. Grindlay K, Lane K, Grossman D. Women’s and provider’s experiences with medical abortion provided through telemedicine. Womens Health Issues. 2013;23:e117-22.
18. Wiebe E. Use of telemedicine for providing medical abortion. Int J Gynaecol Obstet 2014;124:177-8.
19. Raymond E, Grossman D, Wiebe E. Reaching women where they are: eliminating the initial in-person medical abortion visit. Contraception. 2015;92:190-93.
20. Grindlay K, Grossman D. Telemedicine provision of medical abortion in Alaska: through the provider’s lens. J Telemed Tele-care 2017;23:680-5.
21. Larrea S, Palencia L, Pereza G. Aborto farmacológico dispensado a través de un servicio de telemedicina a mujeres de Amé-rica Latina: complicaciones y su tratamiento. Gaceta sanitaria.2014;29(3):198-204.
22. Perry N, Beca JP. Virus ZIKA y aborto por correspondencia, una realidad cercana a Chile. Rev.chil.obstet.gineco. 2017;82(1):89-92.
23. Gomperts RJ, Jelinska K, Davis S, et al. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services. BJOG. 2010;115:1171-5; discussion 1175-8.
24. Aiken A, Digol I, Trussell J. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the republic of Ireland and northern Ireland. BMJ. 2017;357:j2011.
25. Raymond E, Blanchard K. Sixteen years of overregulation: time to unburden mifeprex. N Engl J Med. 2017;376:790-4.
26. The care of women Requesting induced abortion (Evidence-based Clinical Guideline No. 7). . [acceso 15 abril 2018]. Disponi-ble en: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/the-care-of-women-requesting-induced-abortion/
27. Grossman D, Grindlay K, Buchacker T. Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa. Am J Public Health. 2013;103:73-8.
28. Chernick L, Schnall R, Stockwell M. Adolescent female text messaging preferences to prevent pregnancy after an emergency department visit: a qualitative analysis. J Med Internet Res. 2016;18:e261.
29. The Lancet. Does mobile health matter? Lancet 2017;390:2216E.
30. Roopan G, Norman W. Telemedicine and medical abortion: dispelling safety myths, with facts. Mhealth.2018;4(3):1-4.
31. Wainwright M, Colvin C, Swartz A, Leon N. Self-management of medical abortion: a qualitative evidence synthesis. Reprod Health Matters. 2016;24(47):155-67.
32. Jelinskaa K, Yanowb S. Putting abortion pills into women's hands: realizing the full potential of medical abortion. Contracep-tion. 2018;97(2):86-89.
33. Gomperts R, Petow S, Jelinska K, Steen L, Gemzell-danielsson K, kleiverda G. Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine. Acta Obstet Gynecol Scand. 2012;91(2):226-31.
34. Morrison J, Bergauer N, Jacques D, Coleman S, Stanziano G. Telemedicine: Cost-EffectiveManagement Of High-Risk Pregnancy. Manag Care. 2001;10(11):42-6, 48-9.
35. Gomperts R,Van der Vleuten K, Jelinska K, da Costa C, Gemzell-Danielsson K, Kleiverda G. Provision of medical abortion using telemedicine in Brazil. Contraception. 2014;89(2):129-33.

Novedades
Estadísticas
Cómo citar
1.
Fernández Aranda, María Isabel. Perspectivas legales y sociales del uso de la telemedicina en el aborto farmacológico. TESELA, Liderazgo Y Gestión. 2019; 25(1): . Disponible en: http://ciberindex.com/c/ts/e12025 [acceso: 07/12/2019]
Sección
Revisiones
Comentarios

DEJA TU COMENTARIO     VER 0 COMENTARIOS

Normas y uso de comentarios


Hay un total de 0 comentarios


INTRODUCIR NUEVO COMENTARIO

Para enviar un comentario, rellene los campos situados debajo. Recuerde que es obligatorio indicar un nombre y un email para enviar su comentario (el email no sera visible en el comentario).

Nombre:
e-mail:
Comentario: